| MEDFX | MEDHX | MEDFX / MEDHX | |
| Total Expense Ratio | 1.07 | 0.71 | 151% |
| Annual Report Gross Expense Ratio | 1.08 | 0.72 | 150% |
| Fund Existence | 18 years | 20 years | - |
| Gain YTD | 2.817 | 2.926 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.64B | 7.64B | 100% |
| Annual Yield % from dividends | 5.16 | 5.52 | 94% |
| Returns for 1 year | 10.12 | 10.43 | 97% |
| Returns for 3 years | 31.45 | 32.68 | 96% |
| Returns for 5 years | 13.62 | 15.60 | 87% |
| Returns for 10 years | 42.14 | 47.02 | 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GQRIX | 18.60 | 0.30 | +1.64% |
| GQG Partners Global Quality Equity Instl | |||
| MLVMX | 18.56 | 0.23 | +1.25% |
| MFS Low Volatility Equity R1 | |||
| CSGTX | 3.69 | -0.06 | -1.60% |
| Transamerica Small Cap Growth C | |||
| JGVVX | 45.68 | -0.82 | -1.76% |
| JPMorgan Growth Advantage R6 | |||
| WCMEX | 23.97 | -0.54 | -2.20% |
| WCM Focused Emerging Markets Instl | |||